62
Participants
Start Date
July 1, 2013
Primary Completion Date
September 20, 2016
Study Completion Date
October 6, 2017
neratinib
temsirolimus
Memorial Sloan-Kettering Cancer Center, New York
Hopital Nord, Marseille
University of Pittsburgh Cancer Institute, Pittsburgh
Johns Hopkins, Baltimore
CHU de Toulous Hopital Larre, Toulouse
Moffitt Cancer Center, Tampa
Vanderbilt University, Nashville
CHU de Grenoble Hopital Albert Michallon, Grenoble
Ohio State University, Columbus
CHRU de Lille - Hopital Calmette, Lille
Washington University School of Medicine, St Louis
UT Southwestern Medical Center, Dallas
MD Anderson Cancer Center, Houston
University of Colorado, Aurora
City of Hope, Duarte
University of California Los Angeles, Santa Monica
Institut Gustave Roussy, Villejuif
Hopitaux universitaires de Strasbourg Nouvel Hopital Civil, Strasbourg
Beth Israel Deaconess Medical Center, Boston
Dana Farber Cancer Institute, Boston
Massachusettes General Hospital, Boston
Puma Biotechnology, Inc.
INDUSTRY